The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF.
primary studies published RCT
Details- 2011
- Stark LJ
Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
primary studies published RCT
Details- 2011
- Teper A
Efficacy and safety of PANCREAZE(R) for treatment of exocrine pancreatic insufficiency due to cystic fibrosis.
primary studies published RCT
Details- 2011
- Trapnell BC
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.
primary studies published RCT
Details- 2011
- Treggiari MM
Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
primary studies published RCT
Details- 2011
- Van de Vijver E
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.
primary studies published RCT
Details- 2011
- Wainwright CE
Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
primary studies published RCT
Details- 2011
- Wainwright CE
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
primary studies published RCT
Details- 2010
- Accurso FJ
Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
primary studies published RCT
Details- 2010
- Amin R
Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.
primary studies published RCT
Details- 2010
- Buonpensiero P